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Retinoblastoma protein prevents
enteric nervous system defects
and intestinal pseudo-obstruction
Ming Fu,1 Solange Landreville,2 Olga A. Agapova,2 Luke A. Wiley,2
Michael Shoykhet,1 J. William Harbour,2,3 and Robert O. Heuckeroth1,4
1Department

of Pediatrics and 2Department of Ophthalmology and Visual Sciences, Washington University School of Medicine in St. Louis,
St. Louis, Missouri, USA. 3Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
4Department of Developmental, Regenerative and Stem Cell Biology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

The retinoblastoma 1 (RB1) tumor suppressor is a critical regulator of cell cycle progression and development. To investigate the role of RB1 in neural crest–derived melanocytes, we bred mice with a floxed Rb1
allele with mice expressing Cre from the tyrosinase (Tyr) promoter. TyrCre+;Rb1fl/fl mice exhibited no melanocyte defects but died unexpectedly early with intestinal obstruction, striking defects in the enteric nervous
system (ENS), and abnormal intestinal motility. Cre-induced DNA recombination occurred in all enteric
glia and most small bowel myenteric neurons, yet phenotypic effects of Rb1 loss were cell-type specific.
Enteric glia were twice as abundant in mutant mice compared with those in control animals, while myenteric neuron number was normal. Most myenteric neurons also appeared normal in size, but NO-producing
myenteric neurons developed very large nuclei as a result of DNA replication without cell division
(i.e., endoreplication). Parallel studies in vitro found that exogenous NO and Rb1 shRNA increased ENS
precursor DNA replication and nuclear size. The large, irregularly shaped nuclei in NO-producing neurons
were remarkably similar to those in progeria, an early-onset aging disorder that has been linked to RB1
dysfunction. These findings reveal a role for RB1 in the ENS.
Introduction
Chronic intestinal pseudo-obstruction (CIPO) is the clinical indication for 9 percent of small bowel transplants (1), yet the etiology
for these disorders remains poorly understood. CIPO is diagnosed
when bowel motility defects cause functional, but not mechanical,
obstruction, leading to abdominal distension, pain, malnutrition,
and, in severe cases, dependence on parenteral nutrition or intestinal transplantation for survival. It is likely that diverse genetic,
infectious, autoimmune, metabolic, and toxic insults all contribute to CIPO etiology.
Intestinal motility and many other aspects of bowel function are
controlled by an interconnected intrinsic network of neurons and
glia called the enteric nervous system (ENS) (2–4). The ENS forms
from neural crest–derived cells that migrate through fetal bowel,
proliferate extensively, and then exit the cell cycle and differentiate
into many different neuronal subtypes (5–7). Defects in specific
types of enteric neurons may cause life-threatening disease, and,
like in the central nervous system, neurons in the ENS must be
present in the proper ratios and with correct patterning for the
bowel to work well. Signals that control ENS precursor proliferation and cell cycle exit are incompletely understood. Furthermore,
the ENS can be damaged in many ways, often with preferential
effects on NO-producing enteric neurons that inhibit bowel contraction (8). There are also regional differences in the susceptibility
of enteric neurons to damage that are not well understood (9).
We initially intended to develop a model of melanoma by deleting the tumor suppressor retinoblastoma 1 (Rb1) in melanocytes,
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another neural crest derivative. Rb1 is frequently inactivated in
human cancer (10) and critically regulates cell division and development (11–16). Cyclin-dependent kinases promote cell division
by reversibly inactivating RB1 via a hierarchical series of phosphorylation events and sequential conformational changes (12, 13).
The best understood function of RB1 is to induce cell cycle exit
by preventing cells from entering S phase (17), but it also participates in cell cycle checkpoints in S and G2/M phases (14). RB1 is
important not only for tumor suppression but also for development, terminal differentiation, and tissue homeostasis (15), with
mutations causing tissue-specific defects (18, 19). We had previously demonstrated that RB1 couples cell cycle exit with terminal
differentiation in melanocytes (20) and therefore crossed mice
carrying a tyrosinase-Cre (TyrCre) transgene with mice harboring
floxed Rb1 alleles. This TyrCre transgene is expressed not only in
the melanocyte lineage, but also in the developing ENS. We discovered that Rb1 inactivation in the ENS led to a progressive, fatal,
and very unusual defect in a subset of myenteric neurons that produce NO. These cells undergo endoreplication and develop giant,
irregularly shaped nuclei similar to those seen in progeria. Strikingly, although Rb1 is also deleted in enteric glia and other types of
enteric neurons, these cells do not undergo endoreplication, highlighting the complexity of cell cycle regulation and differences in
Rb1 dependence of distinct cell types within the ENS lineage.
Results
Rb1 loss in the ENS causes a severe intestinal motility disorder and early
death. Rb1fl/fl mice were bred with TyrCre mice, and at P8, the resulting
TyrCre+;Rb1fl/fl mice (Rb1 conditional KO [cKO] mice; Figure 1A) were
present at a normal Mendelian ratio (Rb1+/+, 19%; heterozygous Rb1
cKO, 59%; Rb1 cKO, 22%; χ2 test P = 0.5, n = 37 Cre+ mice analyzed).
However, the P8 Rb1 cKO mice were smaller than littermates and
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Figure 1
Rb1 cKO mice gain weight slowly and
die of intestinal pseudo-obstruction.
(A) LoxP sites surrounding Rb1 exon 19
led to inactivation by tyrosinase
promoter–driven Cre-recombinase.
(B) Adult Rb1 cKO mice were smaller
than WT littermates (ruler depicts
centimeters). (C) Rb1 cKO mice die
prematurely; 50% of mice were dead by
P30. (D and E) DSIs of Rb1 cKO mice
become dilated (red arrows) and colons
have hard dark stool scybala at (D) P8
and (E) P30. Ce, cecum; Co, colon;
STM, stomach; SI, small intestine; DSI,
distal small bowel. (F) Rb1 cKO mice
grow slowly (control, n = 33; Rb1 cKO,
n = 33). *P < 0.05.

continued to grow poorly (Figure 1, B and F). By P21, Rb1 cKO mice
were present at a lower ratio than expected (Rb1+/+, 29%; heterozygous
Rb1 cKO, 55%; Rb1 cKO, 16%; χ2 test P < 0.001, n = 806 Cre+ mice
analyzed). By P30, 50% of Rb1 cKO mice had died (Figure 1C).
To determine the cause of death, Rb1 cKO animals were subjected
to necropsy for gross and histopathologic examination of all major
organs. We did not observe any melanocyte defects or tumors, similar to results of Tonks et al. (21), but early death prevented the study
of late-onset melanoma. The only abnormality detected was marked
dilation of the distal small intestine (DSI) with intraluminal stool
or air accumulation and contraction of the more distal bowel. This
phenotype was evident in some Rb1 cKO mice by P8 (Figure 1D;
n = 2 out of 4 examined) and in 70% of mice at 30 days or older
(Figure 1E; WT, n = 14; Rb1 cKO, n = 21), indicating a progressive
bowel motility defect that likely underlies the poor growth and
early death in these mice. Heterozygous TyrCre+;Rb1+/fl mice were
healthy without abnormal phenotype at all ages examined (data not
shown). Because TyrCre mice express Cre in neural crest derivatives,
including the ENS (22–24), we hypothesized that this Rb1 mutation
caused ENS defects.
Rb1 cKO mouse myenteric plexus neurons undergo DNA replication without mitosis. The gross intestinal phenotype in Rb1 cKO mice with
dilated proximal and relatively narrow distal bowel was reminiscent of human Hirschsprung disease, in which the ENS is absent
from the distal bowel. However, histopathologic examination
of mice at various ages from P0 to adulthood did not reveal the
characteristic distal bowel aganglionosis of Hirschsprung disease (n = 33 mice examined). Since the ENS was present, we next
considered the possibility that one or more cell types within the
ENS were abnormal in Rb1 cKO mice. To test this hypothesis,
adult mouse whole-mount preparations of the bowel muscle layers containing the myenteric plexus were stained with antibodies against HuC/D for visualizing neuronal cell bodies, TuJ1 for
visualizing neurites, and S100 or SOX10 for visualizing enteric
glia (Figure 2, A–H). At P30, SOX10 and S100 antibodies labeled
exactly the same cells (100% overlap) in WT and Rb1 cKO mice

(Supplemental Figure 1; supplemental material available online
with this article; doi:10.1172/JCI67653DS1). Quantitative analysis of Rb1 cKO mice demonstrated a normal density of myenteric
neurons in the distal small bowels and colons but a significant
increase in enteric glial density compared with that in WT mice
(Figure 2, I and J). Interestingly, there were also many exceptionally
large neurons (but not glia) in the distal small bowels of Rb1 cKO
mice that were not observed in WT animals (Figure 2, D and H).
Large neurons were seen, but were uncommon, in the colons of Rb1
cKO animals. To further investigate nuclear morphology in distal
small bowel, we used an antibody against the nuclear matrix proteins
lamin A/C (LMNA/C) in combination with HuC/D and the DNA
dye DRAQ5 (Figure 3, A–D). This staining demonstrated very large
nuclei with complex internal and external LMNA/C-containing
lamina. In some cases, LMNA/C “vesicles” are contained within a
larger nuclear lamina, and in others, smaller LMNA/C “vesicles”
are adjacent to or contiguous with a larger nucleus (see Supplemental Figure 2 and Supplemental Videos 1–6). In addition to the
unusual nuclear lamina structures, the large nuclear size suggested
that these neurons might be replicating DNA without cell division
(i.e., endoreplication). Alternatively, nuclear enlargement might be
independent of DNA replication. To distinguish between these possibilities, we first attempted fluorescence-activated cell sorting and
fluorescence in situ hybridization to estimate DNA content, but
these techniques were not successful on the whole-mount preparations required for these studies. Therefore, we used confocal
microscopy and integrated DRAQ5 staining intensity to estimate
DNA content and measure nuclear volume. For these analyses, we
used a lamin B2 antibody that stained the nuclear lamina of myenteric neurons but not those of other cells in the whole-mount preparations (Supplemental Figure 3). This analysis demonstrated that
nuclear volume in Rb1 cKO mice was up to 32-fold larger than that
in WT mice and nuclear volume was directly proportional to DNA
content (Figure 3E), consistent with endoreplication in Rb1 mutant
myenteric neurons. To validate the hypothesis that Rb1 mutant
myenteric neurons continue to replicate DNA after control myen-

The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 12   December 2013

5153

Downloaded on April 20, 2014. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/67653

research article

Figure 2
Rb1 cKO mice have disorganized myenteric ganglia with giant neurons and increased enteric glia. (A–D) Whole-mount preparations of the
myenteric plexus stained with antibodies to HuC/D (red, neuronal marker) and Tuj1 (green, neuron-specific bIII tubulin) demonstrated some very
large myenteric neurons in Rb1 cKO mice. (E and F) S100 (green, glia cytoplasm marker) and HuC/D (red) or (G and H) SOX10 (green, glial
protein), DRAQ5 (blue, DNA dye), and HuC/D (red) immunohistochemistry showed an increased ratio of glia to neurons and normal glial cell
size in ganglia with very large neurons (white arrow in H). (A and B) Ganglia also appear disorganized in Rb1 cKO mice. (I) Quantitative analysis
demonstrated approximately twice as many enteric glia in the distal small bowels and colons of Rb1 cKO mice compared with those in controls.
Neuron numbers were equal in Rb1 cKO and control mice. (J) We confirmed an increased glia to neuron ratio by counting cells within the same
field of view in the distal small bowel and colon. Scale bar: 100 μm (A and B); 50 μm (C–F); 20 μm (G and H). *P < 0.05 versus control. n > 1,000
neurons and >2,000 glia per analysis.

teric neurons have exited the cell cycle, we injected mice with BrdU
daily from P9 to P16 and analyzed the enteric neurons at P20 with
an antibody against BrdU in conjunction with PGP9.5 (neuronal)
and SOX10 (glial) immunohistochemistry. This revealed a marked
increase in BrdU incorporation in neurons of Rb1 cKO mice compared with those in WT mice (Figure 4, A, B, and E), indicating that
Rb1 mutant myenteric neurons continue to replicate DNA at this
age, whereas WT myenteric neurons have ceased DNA synthesis.
Similarly, staining with an antibody against the proliferation marker Ki67 (Figure 4, C, D, and F) showed that Rb1 mutant myenteric
neurons remained in the cell cycle, whereas WT myenteric neurons
had exited the cell cycle at this age. Some SOX10+ enteric glial cells
were also positive for Ki67 and BrdU staining, but the percentages of positive cells did not differ between Rb1 cKO and WT mice
(Figure 4, E and F).
Nuclear enlargement is not likely to be associated with neuronal
cell death, since we were unable to detect TUNEL-positive cells in
the myenteric plexuses of Rb1 cKO or control mice at P30, P50,
5154

or P60 (data not shown). We also did not find evidence of DNA
damage in myenteric neurons by staining with γ-H2AX antibody
(Supplemental Figure 4).
NO-producing distal small bowel myenteric neurons are selectively affected by RB1 loss. We observed a marked variability in the nuclear size
of myenteric plexus neurons in the distal small bowel of Rb1 cKO
mice and hypothesized that RB1 loss may selectively affect certain
types of myenteric neurons. If this were the case, then the affected
cell type would likely be an abundant one, such as NO-producing
inhibitory motor neurons or calretinin-expressing excitatory motor
neurons. To evaluate NO-producing cells, we used nicotinamide
adenine dinucleotide phosphate diaphorase (NADPH-d) staining
on whole-mount preparations of the distal small bowel myenteric
plexus at P8 and P30 (Figure 5). At P30, many NADPH-d–expressing
neurons exhibited giant nuclei, whereas very few giant nuclei were
observed at P8, suggesting that postnatal DNA replication without mitosis in NO-producing myenteric neurons leads to progressive nuclear enlargement. This is consistent with the observation
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Figure 3
Nuclear size correlates with DNA content in myenteric neurons of Rb1 cKO
mice. Immunohistochemistry for LMNA/C
(green, nuclear lamina), HuC/D (red),
and DRAQ5 (blue) demonstrated distal
small bowel myenteric neurons with very
large nuclei (arrow) and irregular shapes
(arrowhead) (C and D) in Rb1 cKO mice
but (A and B) not in WT mice. (E) Integrated DRAQ5 fluorescence intensity
values for nuclei (log2) versus nuclear volume (log2) in distal small bowel myenteric
neurons of P85 control (blue dots) and
Rb1 cKO mice (red dots) demonstrated
a linear correlation between nuclear volume and DNA content in Rb1 cKO nuclei
and confirmed that many nuclei are much
larger than normal in Rb1 cKO mice.
Eight to 10 different Z-stacks per animal
were analyzed. Scale bar: 50 μm.

that the density of NO-producing neurons in the distal small bowels and colons of Rb1 cKO mice was normal (WT DSI, 63 ± 7 per
mm2; Rb1 cKO, 55 ± 8.5 per mm2, P = 0.3; WT colon, 98 ± 13 per
mm2; Rb1 cKO colon, 109 ± 12 per mm2, P = 0.4).
Further, we performed immunohistochemical staining of the
small bowel and colon with antibodies against neuronal NO synthase (nNOS), PGP9.5 (stains all neurons), and calretinin (stains
excitatory motor neurons), along with histochemical staining for
NADPH-d, and performed quantitative analysis (Figure 6). The
giant nuclei (up to 7 times larger than normal cross-sectional
area) were limited to NO-producing neurons in the distal small
bowels of Rb1 cKO mice, whereas calretinin-expressing neurons in
the same region of the bowel had nuclei of normal size (Figure 6,
A, B, E–G, and I). In contrast, there were very few PGP9.5+ neurons
or NADPH-d–expressing neurons in the colon with nuclei that
were larger than normal (Figure 6, C, D, and H). Enteric glia in Rb1
cKO mice also had nuclei with normal appearance. These findings
demonstrate differential effects on the size of neuronal nuclei in
Rb1 cKO mice and selective vulnerability of distal small bowel NOproducing neurons to RB1 loss.
One possible explanation for these findings is that Cre may be
expressed selectively in NO-producing small bowel myenteric neurons. To evaluate this possibility, we studied the pattern of Cre
expression in TyrCre mice by crossing them with a Cre-dependent
enhanced yellow fluorescent protein (EYFP) reporter mouse line.
Quantitative analysis at P30 demonstrated Cre-dependent EYFP
expression in 100% of SOX10+ enteric glia, 62% of distal small
bowel myenteric neurons, 17% of colon myenteric neurons, 93%
of distal small bowel nNOS-expressing myenteric neurons, 90%
of distal small bowel calretinin+ myenteric neurons, 76% of colon
nNOS+ myenteric neurons, and 80% of colon calretinin+ myenteric
neurons (Supplemental Figure 5). We also noted that, in our mice,
12% of colon myenteric neurons had nNOS immunoreactivity
and 12% had calretinin immunoreactivity, lower percentages than
previously reported in BALB/c mice (25). Finally, we performed
immunohistochemistry for PHOX2B in these mice at E10.5
and E11.5 (Supplemental Figure 6) and found that Cre-induced
recombination occurred with some, but not all, ENS precursors by
E10.5 and in almost all ENS precursors by E11.5. Thus, differential

effects of RB1 loss on cells of the ENS cannot be explained on the
basis of asymmetric Cre expression, suggesting that NO-producing
neurons are selectively affected by RB1 loss. We also tested the possibility that differential expression of Rb1 family members p130
and p107 could account for the selective effects on NO-producing
neurons but found that p107 was expressed at low levels in WT
and Rb1 cKO myenteric neurons (Figure 7). In contrast, p130 was
not detected in WT myenteric neurons but was present in all Rb1
cKO myenteric neurons, suggesting that although changes in
p130 protein abundance occur and p107 is present in myenteric
neurons, the expression of these proteins does not account for the
differential effects of Rb1 mutation in myenteric neuron subpopulations or substitute for RB1.
NO causes proliferation of ENS precursors in vitro. The striking effect
of the Rb1 mutation on NO-producing neurons and the limited
effect of this mutation on other enteric neuron types raised the
possibility that NO itself influences DNA replication in ENS
precursors when RB1 activity is low. To test this hypothesis, we
generated a lentivirus that silences Rb1 and confirmed activity
using dissociated E12.5 bowel and quantitative real-time RT-PCR
(qRT-PCR) (Supplemental Figure 7). E12.5 mouse embryonic
midgut slices (300- to 400-μm thick) were then cultured with
GDNF to induce ENS precursors to migrate onto the dish and
treated with Rb1 shRNA lentivirus or a control shRNA-expressing
virus with or without added NO donor (DETA NONOate). Virusinfected ENS precursors identified by GFP and RET expression
were analyzed 48 hours later using phospho-histone 3 (PH3)
immunohistochemistry (Figure 8). These studies demonstrated
that silencing Rb1 and the chemical NO donor DETA NONOate
each independently increased the percentage of RET-expressing
cells that were PH3+ (Figure 8E, 2-way ANOVA, P < 0.001). Furthermore, the NO donor induced the generation of some RET+ cells
with very large nuclei when Rb1 was silenced (Figure 8J), even over
2 days in culture. These data suggest that the striking phenotype
of NO-producing myenteric neurons in Rb1 cKO mice is induced
by a combination of Rb1 loss and high NO levels.
Intestinal motility is abnormal in Rb1 cKO mice. The preceding analysis demonstrated that Rb1 cKO mice die early, develop distal small
bowel dilation, and have very large, unusual NO-producing neu-
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Figure 4
Rb1 cKO mice have an increased
number of BrdU+ and Ki67+ myenteric neurons in the distal small bowel,
but BrdU+ or Ki67+ myenteric neurons were not detected in controls.
Mice were injected with BrdU daily
from P9 to P16 and then sacrificed
at P20. (A–D) Immunohistochemistry
for PGP9.5 (red), SOX10 (purple),
BrdU (green), and Ki67 (green) was
used to detect neurons, glia, DNA
synthesis, and cycling cells, respectively. BrdU+ and Ki67+ neurons and
glia were readily detectable in Rb1
cKO mice. (B) The arrows highlight
a large neuron with BrdU incorporation into the nucleus. (D) The arrows
highlight a Ki67+ neuron. Arrowheads
highlight (B) BrdU+ and (D) Ki67+
glia. BrdU+ and Ki67+ neurons were
not detected in WT mice. (E and F)
Quantitative analysis (n = 200 cells
per bar). Scale bar: 50 μm. *P < 0.05
versus control.

rons in the region in which the bowel is dilated. We hypothesized
that this distal small bowel dilation occurred, at least in part,
because these neurons produced excess NO that caused smooth
muscle relaxation. An additional potential mechanism is that
small bowel dilation occurred because colonic dysfunction prevented luminal contents from exiting the small bowel and entering the colon. If small bowel dilation was due to intrinsic defects,
the distal small bowels of Rb1 cKO mice should remain dilated
and contract poorly even when separated from the colons. To test
this hypothesis, we examined spontaneous contractions of the ilea
from 3 WT and 3 Rb1 cKO mice using an oxygenated organ bath.
The WT small bowel contracted vigorously (Supplemental Video
7), but Rb1 cKO small bowel was dilated (Figure 9) and contracted
5156

very little (Supplemental Video 8), even when separated from
the colon. Direct analysis of distal small bowel muscle layer NO
synthesis, based on conversion of [3H]-arginine to citrulline (26),
also demonstrated 2.8-fold more NO synthesis in Rb1 cKO mice
compared with that in WT mice (WT, 0.69 ± 0.16 cpm/mg/min,
n = 4; Rb1 cKO, 1.93 ± 0.34 cpm/mg/min, n = 3, P = 0.016). For
Rb1 cKO animals, the ilea contracted after addition of the NO
synthesis inhibitor, l-NAME, and motility increased (Figure 9D
and Supplemental Video 10), consistent with the hypothesis that
NO actively inhibited contraction in the Rb1 cKO ileum but bowel
contraction was less obvious after L-NAME addition to WT distal small bowel (Supplemental Video 9). Collectively these data
show that there are serious motility problems in the distal small
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Figure 5
NADPH-d–expressing myenteric neurons with large nuclei appeared
as mice aged. Distal small bowel myenteric plexus neurons were visualized with the NADPH-d method that stains NO-producing neurons.
Large neurons were easy to find after P30 but not present at P8. Arrows
highlight NADPH-d+ neurons in Rb1 cKO mice that are larger than
normal. Scale bar: 100 μm.

bowels of Rb1 cKO mice that could cause poor growth and premature death. Interestingly, colon contractility patterns were also
abnormal in Rb1 cKO mutant mice. In contrast to the control
animals, in which an artificial stool pellet was propelled distally
through the colon (n = 3; Supplemental Video 11), an artificial
stool pellet inserted into the proximal colons of Rb1 cKO mice was
propelled proximally (n = 3; Supplemental Video 12 and Figure 10).
Collectively, these findings demonstrate severe bowel motility
defects and are consistent with the hypothesis that a progressive
intestinal pseudo-obstruction phenotype caused death at between
30 and 120 days of age in Rb1 cKO mice.
Discussion
We discovered an important and previously unsuspected role
for RB1 in the ENS. Mice with conditional, biallelic Rb1 deletion
in the ENS appear healthy at birth but grow slowly and die as
young adults. This early mortality appears due to marked distal small bowel distension and relative contraction of the colon,
consistent with partial obstruction, as a result of ENS dysfunction. When we first observed the phenotype, we considered the
possibility that Rb1 cKO mice had distal bowel aganglionosis
similar to that in human Hirschsprung disease, but many mice
lived longer than would be expected if there were a region without ganglion cells. Furthermore, although there are rare reports
of children with Hirschsprung disease and retinoblastoma, this
probably results from contiguous gene deletion that includes
EDNRB at 13q22 and RB1 at 13q14.2 (27, 28). Instead, we discovered that Rb1 cKO mice had a normal number of myenteric
neurons in the small bowel and colon and a 2-fold increase in
enteric glia. We also found a subset of NO-producing neurons
with very large, irregularly shaped nuclei primarily in the distal
small bowel. Analysis of contractility in isolated bowel segments
demonstrated severe motility defects in both small bowels and
colons of Rb1 cKO mice.

The etiology of intestinal motility problems in Rb1 cKO mice
remains incompletely understood. Our data suggest that the
enlarged nitrergic neurons in distal small bowel produced excess
NO, a neurotransmitter that causes bowel smooth muscle relaxation.
Although this could provide a reasonable explanation for the dilated
distal small bowels observed in most Rb1 cKO mice, colon motility
defects were also evident and probably contributed to poor growth
and early death in these animals. It is possible that the increased
number of enteric glia altered motility in small bowel or colon, since
glia appear to affect synaptic function, but the role of glia in intestinal motility is still poorly understood (29). Furthermore, there are
approximately equal elevations in glial density in the small bowel and
colon, implying that increased glial numbers are unlikely to account
for both poor contractility in the dilated small bowel and for the
abnormal motility in the contracted colon. There is undoubtedly
more to learn about how Rb1 mutations affect ENS function and
bowel motility, but the complexity of neural mechanisms that influence bowel function will make this work challenging.
Intestinal pseudo-obstruction and ENS defects have been
described in previous studies mating TyrCre mice with animals
with Ercc1 floxed alleles (23) or Pten floxed alleles (24), consistent
with efficient recombination of floxed genes within the ENS with
this Cre-expressing mouse line, but the expression pattern of the
TyrCre transgene was not previously well defined. Our analysis
shows that the TyrCre transgene induces DNA recombination in
all enteric glia and most distal small bowel myenteric neurons as
well as in a smaller subset of colon myenteric neurons but not in
other cells of the bowel wall, supporting the hypothesis that the
phenotype observed results from ENS defects.
The ENS phenotype after Rb1 deletion is complex and reflects
the cell-type and context specific roles that RB1 plays in other tissues. RB1 critically regulates the cell cycle by binding to and inhibiting E2F proteins that activate cyclin synthesis. RB1 inactivation
should therefore promote cell cycle entry and, if cell division is
complete, lead to increased cell number. Remarkably, although
Rb1 is inactivated in Rb1 cKO mice in many myenteric neuron
and glial progenitors, we observed 3 distinct cellular outcomes in
many myenteric neuron and glial progenitors. Enteric glia in Rb1
cKO mice appeared to undergo one additional round of cell division, leading to a 2-fold increase in glia number. Many myenteric
neurons, in contrast, did not appear to be affected by Rb1 inactivation or at least did not enter the cell cycle, as demonstrated
by Ki67 staining. However, the most remarkable change occurred
within NO-producing myenteric neurons, in which exceptionally
large and irregularly shaped nuclei appeared to occur as a result
of endoreplication. Endoreplication is a process in which cells go
through G1 and S phases and enter the G2 phase of the cell cycle
but do not undergo mitosis or cytokinesis.
The precise mechanism that induces endoreplication selectively
in NO-producing myenteric neurons in Rb1 cKO mice is unknown.
A plausible hypothesis is suggested by the known biological effects
of NO and RB1. RB1 loss enhances E2F activity, but this is not
enough by itself to induce most postmitotic myenteric neurons to
progress through the cell cycle and start DNA replication. However, NO has complex dose-dependent effects, including the activation of AKT and ERK at low levels. In contrast, at high levels,
NO induces production of toxic-free radicals (e.g., peroxynitrite
anions) that may increase susceptibility of NO neurons to many
types of damage (8, 30–32). Interestingly, NO levels in the hippocampus at baseline, (i.e., without activation of NOS) are in the
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Figure 6
Most giant neurons in distal small bowel myenteric plexus express nNOS. (A–F) Whole-mount myenteric plexus stained with antibodies to nNOS
(green, NO-producing neurons), calretinin (red, excitatory motor neurons), PGP9.5 (red, all neurons), and lamin B2 (green, nuclear lamina) or
by NADPH-d histochemistry (NO-producing neurons). (G–I) Nuclear area for DSI and colon neurons based on lamin B2 staining. Graphs show
cumulative frequency for nuclear area. Each point represents the percentage of neurons with nuclear area smaller than the x axis value in μm2.
(A–D) Typical images of calretinin- and nNOS-expressing neurons in the distal small bowel (A and B) or colon (C and D) myenteric plexus of
control (A and C) orRb1 cKO (B and D) mice. (E and F) Triple labeling for PGP9.5, lamin B2, and NADPH-d in DSIs of control and Rb1 cKO
mice. The arrows highlight a large neuron. (G) Quantitative analysis shows that many NADPH-d–expressing neurons have very large nuclei in
Rb1 cKO mice. Since NADPH-d–expressing neurons are common, it is not surprising that enough PGP9.5+ neurons have large nuclei to shift the
curve. (H) Colon myenteric plexus neurons are very close to normal size in Rb1 cKO mice. (I) In contrast to NO-producing neurons, calretininexpressing myenteric neurons are near normal size in the small intestines of Rb1 cKO mice. Scale bar: 50 μm. (G–I) WT, n = 200 cells; Rb1 cKO,
n = 300 cells per line.
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Figure 7
RB1 family members p107 and
p130 in the DSI of P30 WT and
Rb1 cKO mice were evaluated by
immunohistochemistry. (A) p107
immunoreactivity was detected in
neurites at a low level but not in
neuron cell bodies. (B) p130 immunoreactivity was easily detected in
all myenteric neurons of the Rb1
cKO mouse but was difficult to
detect in the WT mouse. The white
arrows show a myenteric neuron
(HuC/D+) that expresses p130 but
is not stained with NADPH-d histochemistry. Arrowheads show an
NADPH-d histochemistry positive
NO-producing neuron that also
expresses p130. Scale bar: 50 μm
(A and B, lower right), 20 μm.

range that activates ERK and AKT (30). This may be enough to
enhance cell cycle entry in NO-producing neurons but not in adjacent cells that do not produce NO. Consistent with this hypothesis, we demonstrated in vitro that a chemical NO donor increased
levels of histone 3 (H3) phosphorylation in ENS precursors. H3
phosphorylation starts in late G2 phase, increases through late
prophase, and continues through metaphase (33). Dephosphorylation of H3 begins in anaphase and ends in telophase. Thus, our
results are consistent with the hypothesis that Rb1-deficient NOproducing myenteric neurons enter the cell cycle in response to
NO and progress to G2/M but do not complete mitosis, leading to
endoreplication and neurons with very large nuclei.
The reason that NO-producing myenteric neurons do not complete mitosis, while enteric glia and many other cell types proliferate in response to Rb1 loss, is uncertain. However, modeling of the
cell cycle using 45 simultaneous differential equations suggests
that endoreplication occurs when cells have high levels of the
CDH1 (FZR1), an activator of the E3-ubiquitin ligase anaphasepromoting complex (APC) (34). Postmitotic neurons in the central nervous system are known to have high levels of CDH1/APC
activity that regulate axon growth and patterning, and prevent
cell death (35), but we were unable to obtain good antibodies
for immunohistochemistry that would permit colocalization of

CDH1 and nNOS within the myenteric plexus. NO-producing
neurons may therefore selectively enter the cell cycle because of
trophic effects of NO but fail to undergo mitosis, leading to cycles
of endoreplication in the setting of high CDH1 levels common in
postmitotic neurons.
Our observations fit well with recent studies suggesting that
defective RB1 signaling underlies the severe defects in nuclear morphology and aneuploidy seen in several serious human diseases.
For example, Hutchinson-Gilford progeria syndrome is caused by
mutations in the nuclear intermediate filament protein lamin A
(LMNA) gene. The most common disease causing mutation (LMNA
G608G) creates an abnormal splice site, resulting in a 50–amino acid
deletion that eliminates a cleavage site for the protease ZMPSTE24
that normally removes the farnesylated and carboxymethylated
C terminus of LMNA. LMNA binds directly to hypophosphorylated RB1 during the G1 phase of the cell cycle and protects RB1
from proteasomal degradation (36). Gene expression profiling of
HGPS fibroblasts also demonstrated that Rb1 mRNA levels are low
in HGPS cells and that RB1 is the only known LMNA-interacting
protein whose expression is abnormal compared with that of control cells (37). Results of additional studies using a farnesyltransferase inhibitor are consistent with the hypothesis that loss of RB1 is
the primary direct effect of the LMNA mutation studied. A major
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Figure 8
NO donor and Rb1 silencing
increased cell cycle entry in ENS
precursors. (A–H) E12.5 midgut
slices were cultured (B, D, F, and H)
with or (A, C, E, and G) without
the NO donor DETA NONOate and
(C, D, G, and H) with lentivirus
expressing shRNA against Rb1 or
(A, B, E, and F) a control lentivirus for 48 hours. (D and H) Arrowheads indicate Rb1 shRNA lentivirus–infected ENS precursors with
enlarged nuclei in the presence of
NO donor. Antibodies to RET (blue)
and PH3 (red) were used to identify neural crest–derived cells and
cells in the cell cycle, respectively.
(I) Quantitative analysis of neural
crest–derived (RET+), virus-infected
(GFP+) cells in the cell cycle (PH3+).
(J) Quantitative analysis of nuclear
area for RET+GFP+ cells after virus
infection and NO donor or control
culture. In box-and-whisker plot,
horizontal bars indicate the medians, boxes indicate 25th to 75th
percentiles, and whiskers indicate
10th and 90th percentiles. Scale
bar: 20 μm. *P < 0.001 for Rb1
shRNA and for DETA NONOate
versus controls, 2-way ANOVA.

role for reduced RB1 activity in lamin-related diseases is also suggested by the similar appearance of cells from LmnaDhe mice to that
of the nNOS-expressing myenteric neurons in our Rb1 cKO animals (38). The LmnaDhe mutation is a spontaneous semidominant
point mutation (L52R) that causes skin and hair changes that are
similar to those in human progeria. The mutation is in the coiledcoil domain of lamin proteins and is predicted to disrupt structures
needed for self association (39). Defects in nuclear morphology
and misregulation of the cell cycle are also reported in association
with increased RB1 phosphorylation (i.e., inactivation) in TDP-43
mutant mice (40). TDP-43 mutations occur in people with amyotrophic lateral sclerosis, and TDP-43 aggregates are found in many
neurodegenerative diseases. Finally, acute Cre-mediated Rb1 recombination to delete exon 19 using the same conditional mice that we
studied caused increased DNA synthesis, but a block in mitosis in
hepatocytes led to cells with 16N ploidy (19), similar to the effect
in “postmitotic” NO-producing myenteric neurons. In contrast,
acute Rb1 inactivation in the proliferative cells of the gastrointestinal tract of the same mice led to increased DNA synthesis and
increased mitoses without mitotic uncoupling, similar to what
we saw in enteric glia. Progression to mitosis depends on cyclin
B1 accumulation, and differences in cyclin B1 levels may underlie the differences in cellular response after Rb1 inactivation. Our
studies lend strong support for the hypothesis that many of the
5160

LMNA-associated changes in cell cycle control and nuclear morphology are due to reduced RB1 activity.
Summary. Rb1 cKO mice die prematurely with symptoms of intestinal pseudo-obstruction. These mice have serious defects in ENS
structure and intestinal contractility but also have a normal complement of myenteric neurons. The most striking finding is that,
while most myenteric neurons have a normal morphologic appearance, many small bowel NO-producing myenteric neurons undergo
endoreplication as a result of RB1 loss. We hypothesize that the
selective effect of RB1 loss in these cells is a reflection of the unique
biochemistry of NO, which promotes cell proliferation and survival at low levels and damages DNA and proteins at high levels.
Why the NO-producing neurons with giant nuclei are confined to
the small intestine is not known but may reflect differences in NO
production or in Cre expression in colon and small bowel myenteric neurons. The remarkable similarity in nuclear morphology in
small bowel NO-producing myenteric neurons in Rb1 cKO mice to
the enlarged nuclei found in cells with LMNA mutations that cause
progeria is consistent with a critical role for reduced RB1 activity
hypothesized to be important in the pathophysiology of progeria.
Methods
Mice. Characterization of the floxed Rb1, TyrCre, and R26REYFP reporter
mice has been reported previously (22, 41, 42). Floxed Rb1 (Rb1fl/fl) mice
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Figure 9
Rb1 cKO distal small bowel contractility is abnormal. (A and B) Kymographs
were generated from video images
of (A) a WT and (B) a mildly affected
Rb1 cKO mouse distal small bowel
maintained in an oxygenated organ
bath. Bowel lumen was not perfused or
stimulated during video imaging. Mutant
bowel was dilated compared with WT
bowel. (C and D) The same segments
of bowel as in A and B are shown but
with NOS inhibitor l-NAME added within
15 seconds of recording (arrows). Kymographs show the width of the bowel (via
color coding) at a particular position
(x axis) and a particular time (y axis).
Proximal bowel is on the left.

were obtained from the National Cancer Institute Mouse Repository (strain
01XC1; Frederick, Maryland, USA). This strain carries a conditional mutation
in the endogenous Rb1 gene, with LoxP sites inserted into introns surrounding exon 19 (41). Mice with a tyrosinase promoter driving Cre expression
(TyrCre mice) were provided by Graham F. Kay (Queensland Institute of Medical Research, Herston, Queensland, Australia) (22). R26REYFP reporter mice
(B6.129X1-Gt[ROSA]26Sortm1[EYFP]Cos/J) were used to monitor expression of the
Cre transgene (The Jackson Laboratory; C57BL/6J background) (42). TyrCre+
mice (C57BL/6J background) were crossed with floxed Rb1 mice (FVB/129
background), which were subsequently interbred for 5 to 7 generations to
generate Rb1 cKO mice, TyrCre+;Rb1fl/+ (conditional heterozygous Rb1 cKO)
mice, and control mice that either lack Cre or lack floxed Rb1 alleles. Mice
were genotyped for Cre, Rb1, or GFP by PCR analyses, as previously described,
using DNA extracted from tail or ear biopsies (22, 41). For timed pregnancies,
the day on which the vaginal plug was detected was considered E0.5. Survival curves were determined by Kaplan-Meier analysis for Rb1+/+ and Rb1fl/fl
animals carrying the TyrCre transgene (i.e., control and Rb1 cKO animals).
Myenteric whole-mount preparations. Mice were euthanized by carbon dioxide asphyxiation (adult) or cervical dislocation (<P14). The gastrointestinal
tract was removed, flushed with ice-cold PBS, opened by cutting along the
mesenteric border, flattened, and pinned mucosal side down on Sylgard
dishes. After fixation with 4% paraformaldehyde (30 minutes), muscle
layers containing myenteric plexus were separated from mucosa and sub-

mucosa using fine-pointed forceps under a dissecting microscope. Samples from DSI and colon were cut into 1-cm segments and stored in 50%
glycerol/PBS at –20°C until staining and analysis.
Whole-mount immunohistochemistry. Myenteric whole-mount preparations
were permeabilized and blocked with 10% donkey serum/TBST (100 mM
Tris, 150 mM NaCl, 1% Triton X-100) for 1 hour and then incubated for
18 hours at 4°C (or 2 hours at 37°C for lamin antibodies) with the following primary antibodies: mouse biotinylated-HuC/D (1:250; Invitrogen), rabbit TuJ1 (1:10,000; Covance), goat SOX10 (1:250; Santa Cruz Biotechnology
Inc.), goat LMNA/C (1:250; Santa Cruz Biotechnology Inc.), mouse lamin B2
(1:250; Invitrogen), rabbit PGP9.5 (1:500; AbD Serotec), rabbit S100 (1:1,000;
DAKO), rabbit Ki67 (1:250; Abcam), Alexa Fluor 488 conjugated to antiBrdU mouse monoclonal antibody (1:100; Invitrogen), goat calretinin (1:250;
Chemicon), rabbit nNOS (1:250; Chemicon), rabbit γH2AX (1:400; Bethyl
Laboratories), PHOX2B (1:10,000, a gift from J.F. Brunet, Institut de Biologie
de I’École Normale Supérieure, Paris, France), rabbit p107 (C-18) (1:50; Santa
Cruz Biotechnology Inc.), rabbit p130 (C-20) (1:50; Santa Cruz Biotechnology
Inc.), goat RET (1:100; Neuromics), and rabbit PH3 (S10) (1:100; Cell Signaling). Donkey secondary antibodies used were Alexa Fluor 488, 594, or 647
(1:500; Invitrogen). Nuclei were counterstained with DRAQ5 (1:2,000; Cell
Signaling) or DAPI. TUNEL assay was performed with the In Situ Cell Death
Detection TMR Red Kit (Roche Applied Science; positive control: DNase I
treatment). Specimens were mounted on slides in 50% glycerol in PBS and

Figure 10
Rb1 cKO mouse colon contracts abnormally.
Colon was maintained in an oxygenated organ
bath. An artificial stool pellet was inserted into
proximal colon (left). Kymographs show colon
width (by a color code) at specific positions
(x axis) and times (y axis). (A) WT colon propelled
the pellet distally, (B) but Rb1 cKO colon expelled
the pellet from the proximal end.
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observed using upright laser scanning confocal microscopes (Zeiss LSM 510
and Olympus FV1000). Tissue specimens were excited using argon (488 nm),
HeNe1 (543 nm), and HeNe2 (633 nm) lasers, with excitation and barrier filters set for individual fluorophores according to their specific excitation/
emission spectra (λ = 488 nm, 594 nm, 647 nm). The detection pinhole was
set for use with different objectives accordingly. Offset and gain settings were
determined at the start of each experiment and kept constant throughout,
with laser power recorded each time.
Reduced NADPH-d staining. NO-producing inhibitory neurons were visualized in myenteric whole-mount preparations using NADPH-d staining (43).
Stained samples were examined under a bright-field microscope, and neurons
were counted using a 1.0 × 1.0 mm2 grid counting eyepiece (×10 objective).
Twenty randomly selected fields were counted for each region, and data are
presented as neurons per mm2. Contrast and brightness of digital images
were uniformly adjusted with Photoshop.
Nuclear size analysis. Nuclear size of total myenteric, calretinin-expressing,
and NO-producing neurons was determined by triple labeling with
NADPH-d, lamin B2, and PGP9.5 or with calretinin, lamin B2, and PGP9.5
antibodies. A plug-in from ImageJ was used for nuclear area measurements
(μm2), and distribution was plotted as cumulative frequency (%).
BrdU incorporation. Mice were injected with BrdU (100 μg; Invitrogen)
intraperitoneally once daily from P9 to P16 and then analyzed at P20.
Myenteric whole-mount preparations were permeabilized in 0.5% TritonX100 in PBS for 1 hour. DSI and colon were then stained for BrdU using an
Alexa Fluor 488 anti-BrdU mouse monoclonal antibody (1:100; Invitrogen)
for 1 hour at 37°C according to the manufacturer’s instructions. Stained
samples were washed before blocking with 10% donkey serum/TBST for
1 hour and then incubated for triple labeling with PGP9.5 antibody (followed by donkey anti-rabbit Alexa Fluor 594) and SOX10 antibody (followed
by donkey anti-goat Alexa Fluor 647). Specimens were mounted in 50%
glycerol in PBS. PGP9.5+/BrdU+ and SOX10+/BrdU+ (WT mice, n = 4; Rb1
cKO mice, n = 5) cells were counted in 10 fields for each region per mouse
(DSI and colon). Fields were randomly selected using PGP9.5 staining.
DNA content analysis. DSI tissue specimens were stained with lamin B2
antibody to delineate the nuclear lamina of the myenteric neurons. Nuclei
were then counterstained with DRAQ5 to determine their DNA content
(stoichiometric DNA binding; 1:2,000; 12 hours at 4°C). Z-stacks of
myenteric plexuses were recorded using an upright laser scanning confocal microscope (Zeiss LSM 510) with a water immersion ×40 objective
(0.5-μm-thick slices; 8–10 Z-stacks; 30–67 cells per animal). Measure Stack.
java software (OptiNav Inc.) downloaded to the ImageJ plug-ins folder was
used for measurements on a series of slices from Z-stacks. The results were
summed to determine the nuclear volume (log2) and DRAQ5 intensity
(log2; mean gray value of pixels within the nucleus)
Rb1 shRNA. The shRNA plasmid DNA used to generate Rb1 and control
vectors was created by the RNAi core of Washington University in St. Louis
using the vector pLKO.1-puro that also encodes a puromycin resistance
gene (44). The Rb1 target sequence is GCAGTGCGTTATCTACTGAAA.
The control target sequence is CGTCGTATTACAACGTCGTGA. The
puromycin resistance gene was replaced with EGFP from pBK-CMV using
Bamh1 and KpnI to digest both vectors.
Lentivirus production. To produce Rb1 and control shRNA-expressing lentivirus, the plasmids pLKO.1 Rb1 EGFP or pLKO.1 control EGFP (1 μg)
plus Δ8.9 (0.89 μg; BD Biosciences) and VSV-G (0.11 μg; BD Biosciences)
were mixed in 50 μl DMEM plus FuGENE 6 (6 μl per well) for 30 minutes
at room temperature. The plasmid mixture was added to HEK293T cells
in 30-mm dishes (6-well dishes). Medium was replaced with 2 ml fresh
DMEM plus chicken embryo extract (10%) 16 hours after transfection. The
culture supernatants with virus particles were collected after 48 hours. To
eliminate the cell debris, supernatant was centrifuged for 10 minutes at
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4°C at 500 × g, filtered with a 0.22-μm syringe top filter, and stored in
aliquots at –80°C until use.
qRT-PCR. Bowel from E12.5 CF-1 mouse was dissociated with dispase and
collagenase and cultured as described previously (45). Lentivirus was added
after 16 hours of culture. Medium was replaced after 24 hours, and cells
were collected for RNA purification 48 hours after virus addition. Reverse
transcription was carried out using 10 ng total RNA and SuperScript III
(Invitrogen) following the manufacturer’s protocol. Fast SYBR Green Master Mix (Applied Biosystems) was used to quantify relative Rb1 mRNA levels
by qRT-PCR with a Mx3005P (Agilent Technologies) instrument and Rb1
primers (forward 5′CCTTGAACCTGCTTGTCCTC3′, reverse 5′TGAGGCTGCTTGTGTCTCTG3′) as well as GAPDH primers (forward 5′AACTTTGGCATTGTGGAAGG3′, reverse 5′ GGATGCAGGGATGATGTTCT3′).
ENS precursor culture for Rb1 shRNA and DETA NONOate studies. E12.5
mouse midgut slices (300- to 400-μm thick) were cultured on fibronectincoated (250 μg/ml; GIBCO) 8-well glass chamber slides (NUNC, catalog
no. 177402) in DMEM with chicken embryo extract (10% chicken embryo
extract; Seralab); N2 (1%; Invitrogen); B27 (2%; Invitrogen); bFGF (20 ng/ml;
R&D Systems); EGF (20 ng/ml; Calbiochem); retinoic acid (35 ng/ml;
Sigma-Aldrich); and β-mercaptoethanol (50 μM; Sigma-Aldrich). Four
hours after plating, GDNF was added (50 ng/ml) to induce enteric neural
crest–derived cell migration from the slice. Sixteen hours later, cultures
were treated with control virus (5 × 106 CFU/ml) or Rb1 shRNA virus
(2 × 106 CFU/ml) containing medium and DETA NONOate (Cayman).
Medium was replaced with fresh DMEM, chicken embryo extract, and DETA
NONOate after 24 hours, and cultures were fixed (30 minutes at 25°C) in
4% paraformaldehyde 48 hours after virus and DETA NONOate addition.
Functional motility analysis. DSIs and colons from Rb1 cKO and WT littermates were pinned to Sylgard and maintained in a 37°C water bath with
20 ml oxygenated (95% O2 and 5% CO2) physiological saline solution of the
following composition: 1x Krebs buffer (Sigma-Aldrich, product no. K4002)
with additional d-glucose 2 g/l, NaHCO3 2.1 g/l, and CaCl2 0.28 g/l. The
saline was continuously superfused through the organ bath at a flow rate of
15 ml/min. After 30 minutes equilibration, an artificial pellet was placed at
the proximal end of the colon. Video images were recorded for 25 minutes
before adding a NOS blocker (100 μM l-NAME) (Cayman) to the water bath.
Video imaging. Video images were captured at ×0.67 optical magnification
with an E-PM1 Olympus digital video camera mounted on a dissecting
microscope (15 frames per second, 1,920 × 1,080 pixels resolution). AVIDEMUX version 2.6.1 software was used to convert MTS to Avi format. Then,
files were converted from Avi to SU2 format using software (Scribble v.2)
provided by Joel C. Bornstein (Department of Physiology, University of
Melbourne, Parkville, Victoria, Australia). Finally, spatiotemporal maps
were generated and analyzed with custom software (Analyze) also developed by Joel C. Bornstein’s group using MATLAB 7.0.4. (46).
Measurement of NO synthesis in bowel muscle layers. The small intestine from
10 cm distal to the stomach to 10 cm proximal to the cecum was dissected
in oxygenated 1× Krebs buffer (Sigma-Aldrich, product no. K4002) with
additional 2 g/l d-glucose, 2.1 g/l NaHCO3, and 0.28 g/l CaCl2 to separate
smooth muscle layers, including the myenteric plexus from submucosa and
mucosa. These muscle layers were incubated in l-[3H] arginine (3 μCi/ml;
PerkinElmer) at 37°C for 15 minutes to permit conversion of arginine to
citrulline and NO. Tissue was flash frozen in liquid nitrogen and stored
at –80°C until analysis. l-[3H] citrulline was extracted by homogenizing
weighed muscle preparations (Dounce homogenizer) and precipitating protein with 1 M trichloroacetic acid (Sigma-Aldrich), water/ether extraction
(×3), and column chromatography (Dowex AG50WX-8 [Sigma-Aldrich]
Na+form) as described previously (26) before scintillation counting.
Statistics. Student’s t test was used when comparing WT mice to Rb1 cKO
mice. For studies in which enteric neural crest–derived cells were treated
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with Rb1 shRNA and DETA NONOate in vitro, a 2-way ANOVA was performed. Data were analyzed for statistical significance using MedCalc software version 9.5.1.0 (http://medcalcsoftware.com/medcalc.php), R version
2.15 (R Foundation), or SigmaPlot version 11.2. For all studies, the sample
size included 3 or more mice for each genotype. The values are represented
as mean ± SEM, and P < 0.05 was considered significant.
Study approval. The Animal Studies Committee of Washington University
School of Medicine in St. Louis approved all experiments with animals.

Acknowledgments
The authors would like to thank Graham F. Kay (Queensland
Institute of Medical Research, Australia) for providing TyrCre
mice, Suellen C. Greco from Division of Comparative Medicine
for animal pathology reports, Frank E. Schottler in the Immunomorphology Core Lab for his technical help with confocal
microscopy, Richard Heil-Chapdelaine for expert guidance generating confocal 3-dimensional images, and Susana Gonzalo
for helpful advice on lamin proteins. We also thank S. Celeste
Morley and Elizabeth Todd for help with γ-irradiation, Werend
Boesmans and Joel Bornstein for expert guidance on intestinal
motility testing and for sharing software, Allan Doctor and John
R. Grider for advice on NO analyses, and Jonathan Lake for assistance with motility studies and statistical analyses. This work
was supported by Fonds de la Recherche du Québec-Santé Postdoctoral Training Award (to S. Landreville), Knights Templar Eye
Foundation Postdoctoral Research Fellowship (to L. Wiley), Children’s Discovery Institute CDI-FR-2011-145 (to M. Shoykhet),
Scholar of the Child Health Research Center at Washington
University School of Medicine in St. Louis K12-HD076224 (to
M. Shoykhet), NIH KO8 NS082362-01 (to M. Shoykhet), NIH
R01 DK087715 and R01 DK57038 (to R.O. Heuckeroth), Burroughs Wellcome Fund Clinical Scientist Award in Translational
1. O’Keefe SJ, Matarese L. Small bowel transplantation. Curr Gastroenterol Rep. 2006;8(5):360–366.
2. Sasselli V, Pachnis V, Burns AJ. The enteric nervous
system. Dev Biol. 2012;366(1):64–73.
3. Furness JB. The Enteric Nervous System. Malden,
Massachusetts, USA: Blackwell Publishing; 2006.
4. Grundy D, Schemann M. Enteric nervous system.
Curr Opin Gastroenterol. 2005;21(2):176–182.
5. Newgreen D, Young HM. Enteric nervous system:
development and developmental disturbances —
part 1. Pediatr Dev Pathol. 2002;5(3):224–247.
6. Heanue TA, Pachnis V. Enteric nervous system development and Hirschsprung’s disease: advances in
genetic and stem cell studies. Nat Rev Neurosci. 2007;
8(6):466–479.
7. Goldstein A, Hofstra R, Burns A. Building a brain
in the gut: development of the enteric nervous
system. Clin Genet. 2012;83(4):307–316.
8. Rivera LR, Poole DP, Thacker M, Furness JB. The
involvement of nitric oxide synthase neurons in
enteric neuropathies. Neurogastroenterol Motil. 2011;
23(11):980–988.
9. Viader A, Wright-Jin EC, Vohra BP, Heuckeroth
RO, Milbrandt J. Differential regional and subtypespecific vulnerability of enteric neurons to mitochondrial dysfunction. PLoS One. 2011;6(11):e27727.
10. Burkhart DL, Sage J. Cellular mechanisms of
tumour suppression by the retinoblastoma gene.
Nat Rev Cancer. 2008;8(9):671–682.
11. Delston RB, Matatall KA, Sun Y, Onken MD, Harbour JW. p38 phosphorylates Rb on Ser567 by a
novel, cell cycle-independent mechanism that triggers
Rb-Hdm2 interaction and apoptosis. Oncogene. 2011;
30(5):588–599.
12. Lundberg AS, Weinberg RA. Functional inactiva-

Research 1008525 (to R.O. Heuckeroth), Children’s Discovery
Institute of Washington University and St. Louis Children’s
Hospital (CH-II-1008-123 and CH-II-2013-269) (to R.O. Heuckeroth), NIH R01 EY13169 (to J.W. Harbour), Research to Prevent Blindness (to J.W. Harbour), and an unrestricted grant to
the Department of Ophthalmology and Visual Sciences from
Research to Prevent Blindness Inc., and the NIH Vision Core
grant P30 EY02687. The Washington University RNAi core is
supported by the Children’s Discovery Institute of Washington
University and St. Louis Children’s Hospital (CDI-LI-2010-94),
The RNAi Consortium (TRC), and The Genome Institute at
Washington University (TGI).
Received for publication November 1, 2012, and accepted in
revised form August 15, 2013.
Address correspondence to: J. William Harbour, Bascom
Palmer Eye Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 900 N.W.
17th Street, Miami, Florida 33136, USA. Phone: 305.326.6166;
Fax: 305.326.6417; E-mail: jwharbour@med.miami.edu. Or to:
Robert O. Heuckeroth, Irma and Norman Braman Endowed
Chair for Research in GI Motility Disorders, The Children’s
Hospital of Philadelphia Research Institute, 3615 Civic Center
Blvd., Abramson Research Center — Suite #1116I, Philadelphia,
Pennsylvania 19104-4318, USA. Phone: 215.590.1209; Fax:
215.590.3324; E-mail: HeuckerothR@email.chop.edu.
Robert O. Heuckeroth’s present address is: Irma and Norman
Braman Endowed Chair for Research in GI Motility Disorders,
The Children’s Hospital of Philadelphia Research Institute,
Philadelphia, Pennsylvania, USA.

tion of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk
complexes. Mol Cell Biol. 1998;18(2):753–761.
13. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean
DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb
functions as cells move through G1. Cell. 1999;
98(6):859–869.
14. Genovese C, Trani D, Caputi M, Claudio PP. Cell
cycle control and beyond: emerging roles for
the retinoblastoma gene family. Oncogene. 2006;
25(38):5201–5209.
15. Lipinski MM, Jacks T. The retinoblastoma gene
family in differentiation and development. Oncogene. 1999;18(55):7873–7882.
16. Slack RS, Miller FD. Retinoblastoma gene in mouse
neural development. Dev Genet. 1996;18(1):81–91.
17. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee
WH. The retinoblastoma gene product regulates
progression through the G1 phase of the cell cycle.
Cell. 1991;67(2):293–302.
18. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM,
Jacks T. Acute mutation of retinoblastoma gene
function is sufficient for cell cycle re-entry. Nature.
2003;424(6945):223–228.
19. Bourgo RJ, Ehmer U, Sage J, Knudsen ES. RB deletion disrupts coordination between DNA replication licensing and mitotic entry in vivo. Mol Biol
Cell. 2011;22(7):931–939.
20. Loercher AE, Tank EM, Delston RB, Harbour JW.
MITF links differentiation with cell cycle arrest
in melanocytes by transcriptional activation of
INK4A. J Cell Biol. 2005;168(1):35–40.
21. Tonks ID, et al. Melanocyte homeostasis in vivo tolerates Rb1 loss in a developmentally independent fash-

ion. Pigment Cell Melanoma Res. 2010;23(4):564–570.
22. Tonks ID, et al. Tyrosinase-Cre mice for tissuespecific gene ablation in neural crest and neuroepithelial-derived tissues. Genesis. 2003;37(3):131–138.
23. Selfridge J, Song L, Brownstein DG, Melton DW.
Mice with DNA repair gene Ercc1 deficiency in
a neural crest lineage are a model for late-onset
Hirschsprung disease. DNA Repair (Amst). 2010;
9(6):653–660.
24. Puig I, Champeval D, De Santa Barbara P, Jaubert F, Lyonnet S, Larue L. Deletion of Pten in the
mouse enteric nervous system induces ganglioneuromatosis and mimics intestinal pseudoobstruction. J Clin Invest. 2009;119(12):3586–3596.
25. Sang Q, Williamson S, Young HM. Projections of
chemically identified myenteric neurons of the
small and large intestine of the mouse. J Anat. 1997;
190(pt 2):209–222.
26. Bredt DS, Snyder SH. Nitric oxide mediates
glutamate-linked enhancement of cGMP levels
in the cerebellum. Proc Natl Acad Sci U S A. 1989;
86(22):9030–9033.
27. Weigel BJ, Pierpont ME, Young TL, Mutchler SB,
Neglia JP. Retinoblastoma and Hirschsprung disease in a patient with interstitial deletion of chromosome 13. Am J Med Genet. 1998;77(4):285–288.
28. Sparkes RS, Sparkes MC, Kalina RE, Pagon RA,
Salk DJ, Disteche CM. Separation of retinoblastoma and esterase D loci in a patient with sporadic
retinoblastoma and del(13)(q14.1q22.3). Hum
Genet. 1984;68(3):258–259.
29. Gulbransen BD, Sharkey KA. Novel functional
roles for enteric glia in the gastrointestinal tract.
Nat Rev Gastroenterol Hepatol. 2012;9(11):625–632.
30. Lourenco CF, Santos R, Barbosa RM, Gerhardt G,

The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 12   December 2013

5163

Downloaded on April 20, 2014. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/67653

research article
Cadenas E, Laranjinha J. In vivo modulation of
nitric oxide concentration dynamics upon glutamatergic neuronal activation in the hippocampus.
Hippocampus. 2011;21(6):622–630.
31. Thomas DD, et al. The chemical biology of nitric
oxide: implications in cellular signaling. Free Radic
Biol Med. 2008;45(1):18–31.
32. Carreira BP, et al. Nitric oxide stimulates the proliferation of neural stem cells bypassing the epidermal growth factor receptor. Stem Cells. 2010;
28(7):1219–1230.
33. Hans F, Dimitrov S. Histone H3 phosphorylation
and cell division. Oncogene. 2001;20(24):3021–3027.
34. Gerard C, Goldbeter A. Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc Natl Acad Sci U S A. 2009;
106(51):21643–21648.
35. Almeida A, Bolanos JP, Moreno S. Cdh1/Hct1-APC
is essential for the survival of postmitotic neurons.
J Neurosci. 2005;25(36):8115–8121.
36. Johnson BR, et al. A-type lamins regulate retinoblastoma protein function by promoting

5164

subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci U S A. 2004;
101(26):9677–9682.
37. Marji J, et al. Defective lamin A-Rb signaling in
Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition. PLoS One. 2010;
5(6):e11132.
38. Pratt CH, Curtain M, Donahue LR, Shopland LS.
Mitotic defects lead to pervasive aneuploidy and
accompany loss of RB1 activity in mouse LmnaDhe
dermal fibroblasts. PLoS One. 2011;6(3):e18065.
39. Odgren PR, et al. Disheveled hair and ear (Dhe),
a spontaneous mouse Lmna mutation modeling
human laminopathies. PLoS One. 2010;5(4):e9959.
40. Ayala YM, Misteli T, Baralle FE. TDP-43 regulates retinoblastoma protein phosphorylation through the
repression of cyclin-dependent kinase 6 expression.
Proc Natl Acad Sci U S A. 2008;105(10):3785–3789.
41. Marino S, Vooijs M, van Der Gulden H, Jonkers J,
Berns A. Induction of medulloblastomas in p53null mutant mice by somatic inactivation of Rb in
the external granular layer cells of the cerebellum.

Genes Dev. 2000;14(8):994–1004.
42. Srinivas S, et al. Cre reporter strains produced
by targeted insertion of EYFP and ECFP into the
ROSA26 locus. BMC Dev Biol. 2001;1:4.
43. Neuhuber WL, Worl J, Berthoud HR, Conte B.
NADPH-diaphorase-positive nerve fibers associated with motor endplates in the rat esophagus: new
evidence for co-innervation of striated muscle by
enteric neurons. Cell Tissue Res. 1994;276(1):23–30.
44. Moffat J, et al. A lentiviral RNAi library for human
and mouse genes applied to an arrayed viral highcontent screen. Cell. 2006;124(6):1283–1298.
45. Sato Y, Heuckeroth RO. Retinoic acid regulates
murine enteric nervous system precursor proliferation, enhances neuronal precursor differentiation,
and reduces neurite growth in vitro. Dev Biol. 2008;
320(1):185–198.
46. Roberts RR, Murphy JF, Young HM, Bornstein
JC. Development of colonic motility in the
neonatal mouse-studies using spatiotemporal
maps. Am J Physiol Gastrointest Liver Physiol. 2007;
292(3):G930–G938.

The Journal of Clinical Investigation   http://www.jci.org   Volume 123   Number 12   December 2013

